- Antibacterial evaluation of structurally amphipathic, membrane active small cationic peptidomimetics: Synthesized by incorporating 3-amino benzoic acid as peptidomimetic element
-
A new series of small cationic peptidomimetics were synthesized by incorporating 3-amino benzoic acid (3-ABA) in a small structural framework with the objective to mimic essential properties of natural antimicrobial peptides (AMPs). The new design approac
- Lohan, Sandeep,Cameotra, Swaranjit Singh,Bisht, Gopal Singh
-
-
Read Online
- Development of novel membrane active lipidated peptidomimetics active against drug resistant clinical isolates
-
A new series of small cationic lipidated peptidomimetics have been synthesized and found to be highly active against several susceptible as well as drug resistant clinical isolates of bacteria and fungi. All lipidated peptidomimetics do not cause signific
- Lohan, Sandeep,Kalanta, Arneesh,Sonkusre, Praveen,Cameotra, Swaranjit Singh,Bisht, Gopal Singh
-
-
Read Online
- Preptin analogues: Chemical synthesis, secondary structure and biological studies
-
Peptide hormones that modulate insulin secretion have been recognized to have therapeutic potential, with peptides such as amylin (pramlintide acetate, Symlin) and exendin-4 (exenatide, Byetta) now commercially available. Preptin is a peptide that has been shown to increase insulin secretion in vitro and in vivo. Here, we describe the first chemical synthesis and analysis of a short series of preptin analogues based on the rat preptin sequence. Phe 21 in the preptin sequence was substituted with the non-protein amino acids D-Phe, D-Hphe, 3-aminobenzoic acid and 1-aminocyclooctane-1-carboxylic acid, which rendered the preptin analogues resistant to chymotryptic protease hydrolysis at this position. Substitution of Phe 21 with these non-protein amino acids did not abrogate the insulin secretory effect of preptin, with analogues showing a similar dose-dependent effect on insulin secretion from βTC6-F7 mouse β-cells in both the presence and absence of glucose as unmodified rat preptin. Further studies on the stability of the preptin analogues and their effect on insulin secretion are in progress.
- Buchanan, Christina M.,Peng, Zhenzhen,Cefre, Aiko,Sarojini, Vijayalekshmi
-
-
Read Online
- Synthesis, molecular docking analysis and biological evaluations of saccharide-modified thiadiazole sulfonamide derivatives
-
A series of saccharide-modified thiadiazole sulfonamide derivatives has been designed and synthesized by the “tail approach” and evaluated for inhibitory activity against carbonic anhydrases II, IX, and XII. Most of the compounds showed high topological polar surface area (TPSA) values and excellent enzyme inhibitory activity. The impacts of some compounds on the viability of HT-29, MDA-MB-231, and MG-63 human cancer cell lines were examined under both normoxic and hypoxic conditions, and they showed certain inhibitory effects on cell viability. Moreover, it was found that the series of compounds had the ability to raise the pH of the tumor cell microenvironment. All the results proved that saccharide-modified thiadiazole sulfonamides have important research prospects for the development of CA IX inhibitors.
- Zhang, Zuo-Peng,Zhong, Ye,Han, Zhen-Bin,Zhou, Lin,Su, Hua-Sheng,Wang, Jian,Liu, Yang,Cheng, Mao-Sheng
-
-
- Beyond Basicity: Discovery of Nonbasic DENV-2 Protease Inhibitors with Potent Activity in Cell Culture
-
The viral serine protease NS2B-NS3 is one of the promising targets for drug discovery against dengue virus and other flaviviruses. The molecular recognition preferences of the protease favor basic, positively charged moieties as substrates and inhibitors, which leads to pharmacokinetic liabilities and off-target interactions with host proteases such as thrombin. We here present the results of efforts that were aimed specifically at the discovery and development of noncharged, small-molecular inhibitors of the flaviviral proteases. A key factor in the discovery of these compounds was a cellular reporter gene assay for the dengue protease, the DENV2proHeLa system. Extensive structure-activity relationship explorations resulted in novel benzamide derivatives with submicromolar activities in viral replication assays (EC50 0.24 μM), selectivity against off-target proteases, and negligible cytotoxicity. This structural class has increased drug-likeness compared to most of the previously published active-site-directed flaviviral protease inhibitors and includes promising candidates for further preclinical development.
- Kühl, Nikos,Leuthold, Mila M.,Behnam, Mira A. M.,Klein, Christian D.
-
supporting information
p. 4567 - 4587
(2021/05/06)
-
- Discovery of Novel Nonpeptidic PAR2 Ligands
-
Proteinase-activated receptor 2 (PAR2) is a class A G protein-coupled receptor whose activation has been associated with inflammatory diseases and cancer, thus representing a valuable therapeutic target. Pathophysiological roles of PAR2 are often characterized using peptidic PAR2 agonists. Peptidic ligands are frequently unstable in vivo and show poor bioavailability, and only a few approaches toward drug-like nonpeptidic PAR2 ligands have been described. The herein-described ligand 5a (IK187) is a nonpeptidic PAR2 agonist with submicromolar potency in a functional assay reflecting G protein activation. The ligand also showed substantial β-arrestin recruitment. The development of the compound was guided by the crystal structure of PAR2, when the C-terminal end of peptidic agonists was replaced by a small molecule based on a disubstituted phenylene scaffold. IK187 shows preferable metabolic stability and may serve as a lead compound for the development of nonpeptidic drugs addressing PAR2.
- Gmeiner, Peter,Hübner, Harald,Kaindl, Jonas,Kl?sel, Ilona,Schmidt, Maximilian F.,Weikert, Dorothee
-
supporting information
p. 1316 - 1323
(2020/07/04)
-
- Can self-assembled hydrogels composed of aromatic amino acid derivatives function as drug delivery carriers?
-
Low molecular weight hydrogelators (LMOHGs) have attracted recent attention due to their diversified applications. In an attempt to artificially imitate their importance in the design of drug delivery carriers, we have synthesized two simple N-terminally protected aromatic amino-acid derivatives that form efficient stable hydrogels at room temperature. The gelation properties of the hydrogels have been thoroughly investigated using various techniques and their strength has been determined by rheological studies. In order to explore the efficacy of the hydrogels as tools for drug delivery, we have developed hydrogel nanoparticles (HNPs) using a surfactant and high-speed homogenization approach. Interestingly, our hydrogel nanoparticles display good entrapment efficiency and release kinetics of the model drug 5-fluoro uracil from the hydrogel matrix. Our experimental results reveal that hydrogel II displays slightly higher efficiency as a drug delivery carrier, which may be due to the presence of an aromatic ring in the backbone in comparison to hydrogel I. This increased strength may be attributed to the increase in π-π interactions when the aromatic residue is present in the backbone. Therefore the nanoparticles generated from hydrogel II may have better hydrogen bonding abilities with drugs in comparison to hydrogel I; thus resulting in a slightly slower release of drug from the hydrogel matrix. This fact may shed some light on the candidature of our hydrogels as future carriers for drug delivery. However, further studies to evaluate the candidature of these novel types of aromatic amino acid hydrogel nanoparticles for nano-medical applications are under investigation.
- Tiwari, Priyanka,Rajagopalan, Ramanathan,Moin, Mohammad,Soni, Rohit,Trivedi, Piyush,DuttKonar, Anita
-
p. 308 - 315
(2016/12/30)
-
- Introduction of cyclically constrained γ-residues stabilizes an α-peptide hairpin in aqueous solution
-
The synthesis and structural characterization of hybrid α/γ-peptides resulting from a 1:1 α→γ residue substitution at cross-strand positions in a hairpin-forming α-peptide sequence are described. Cyclically constrained γ-residues based on 1,3-substituted
- Lengyel, George A.,Eddinger, Geoffrey A.,Horne, W. Seth
-
supporting information
p. 944 - 947
(2013/04/10)
-
- Novel multi-cyclic compounds and their use
-
Pharmaceutical compositions comprising at least one compound of the formulas (Ia) or (Ib) or (IIa) or (IIb) and a pharmaceutically acceptable carrier which is useful in a medicine wherein the symbols and substituents have the following meaning -X- is e.g.
- -
-
Page/Page column 18
(2008/06/13)
-
- Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
-
The invention encompasses ureido substituted benzoic acid compounds, compositions comprising the compounds and methods for treating or preventing diseases associated with nonsense mutations of mRNA by administering these compounds or compositions.
- -
-
Page/Page column 50
(2008/06/13)
-
- UREIDO SUBSTITUTED BENZOIC ACID COMPOUNDS AND THEIR USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASE
-
The invention encompasses ureido substituted benzoic acid compounds, compositions comprising the compounds and methods for treating or preventing diseases associated with nonsense mutations of mRNA by administering these compounds or compositions.
- -
-
-